Hikma Pharmaceutical | HIK - Pre Tax Profit

Stock Price
1,383.50
Daily Change
-13.50 -0.97%
Monthly
10.06%
Yearly
-30.30%
Q2 Forecast
1,361.73

Hikma Pharmaceutical reported $147.5M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Almirall EUR 30.32M 22M Dec/2025
argenx SE USD 386.05M 99.15M Sep/2025
AstraZeneca USD 2.63B 615M Dec/2025
Autolus Therapeutics Ltd USD -91.52M 12.93M Dec/2025
Bayer EUR -1.16B 735M Sep/2025
Fresenius EUR 601M 122M Dec/2025
Galapagos EUR -221.49M 117.07M Sep/2025
Genmab DKK 55M 427M Dec/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 1.29B 458.1M Sep/2025
Orion EUR 113.4M 213.6M Mar/2026
Recordati EUR 144.95M 25.46M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025